Graham co-founded Remap Consulting in 2014 with the mission to help clients optimise theirpricing, health economics and market access outcomes.
With over 20 years pharmaceutical experience Graham brings unparalleled expertise in developing global product launch strategies and producing HTA submissions to address payers’ pricing and reimbursement requirements.

Graham’s industry experience includes GSK, start-up biotech companies and Ferring
pharmaceuticals. During his time at Ferring, Graham was the Global Head of Market Access taking responsibility for all market access activities.

Graham’s consultancy experience was obtained within both IMS consulting (previously Cambridge Pharma) and Adelphi Values whereby he was responsible for global pricing and reimbursement projects ranging from EU pricing and reimbursement submissions, strategic insights to global pharmaceutical companies and development of biosimilar access strategies.

Visit web : www.remapconsulting.com